Suppr超能文献

在基于哺乳动物细胞的生物测定中使用病毒启动子:可靠性如何?

Use of viral promoters in mammalian cell-based bioassays: How reliable?

作者信息

Betrabet Shrikant S, Choudhuri Jyoti, Gill-Sharma Manjit

机构信息

National Institute for Research in Reproductive Health, (ICMR), Jahangir Merwanji Street, Parel, Mumbai,400 012, India.

出版信息

J Transl Med. 2004 Jan 14;2(1):1. doi: 10.1186/1479-5876-2-1.

Abstract

Cell-based bioassays have been suggested for screening of hormones and drug bioactivities. They are a plausible alternative to animal based methods. The technique used is called receptor/reporter system. Receptor/reporter system was initially developed as a research technique to understand gene function. Often reporter constructs containing viral promoters were used because they could be expressed with very 'high' magnitude in a variety of cell types in the laboratory. On the other hand mammalian genes are expressed in a cell/tissue specific manner, which makes them (i.e. cells/tissues) specialized for specific function in vivo. Therefore, if the receptor/reporter system is to be used as a cell-based screen for testing of hormones and drugs for human therapy then the choice of cell line as well as the promoter in the reporter module is of prime importance so as to get a realistic measure of the bioactivities of 'test' compounds. We evaluated two conventionally used viral promoters and a natural mammalian promoter, regulated by steroid hormone progesterone, in a cell-based receptor/reporter system. The promoters were spliced into vectors expressing enzyme CAT (chloramphenicol acetyl transferase), which served as a reporter of their magnitudes and consistencies in controlling gene expressions. They were introduced into breast cell lines T47D and MCF-7, which served as a cell-based source of progesterone receptors. The yardstick of their reliability was highest magnitude as well as consistency in CAT expression on induction by sequential doses of progesterone. All the promoters responded to induction by progesterone doses ranging from 10-12 to 10-6 molar by expressing CAT enzyme, albeit with varying magnitudes and consistencies. The natural mammalian promoter showed the most coherence in magnitude as well as dose dependent expression profile in both the cell lines. Our study casts doubts on use of viral promoters in a cell-based bioassay for measuring bioactivities of drugs and hormones for human therapy and suggests caution regardingtranslation in toto, of a research technique as a cell-based bioassay for drug screening.

摘要

基于细胞的生物测定法已被建议用于激素和药物生物活性的筛选。它们是基于动物的方法的一种合理替代方案。所使用的技术称为受体/报告系统。受体/报告系统最初是作为一种研究技术开发的,用于理解基因功能。通常使用含有病毒启动子的报告构建体,因为它们可以在实验室中的多种细胞类型中以非常“高”的水平表达。另一方面,哺乳动物基因以细胞/组织特异性方式表达,这使得它们(即细胞/组织)在体内专门执行特定功能。因此,如果受体/报告系统要用作基于细胞的筛选方法,用于测试用于人类治疗的激素和药物,那么细胞系的选择以及报告模块中的启动子至关重要,以便获得对“测试”化合物生物活性的实际测量。我们在基于细胞的受体/报告系统中评估了两种常规使用的病毒启动子和一种受类固醇激素孕酮调节的天然哺乳动物启动子。这些启动子被剪接到表达酶CAT(氯霉素乙酰转移酶)的载体中,该酶用作它们在控制基因表达方面的强度和一致性的报告物。它们被引入乳腺细胞系T47D和MCF-7,这两种细胞系用作孕酮受体的细胞来源。它们可靠性的衡量标准是在连续剂量的孕酮诱导下CAT表达的最高水平以及一致性。所有启动子在孕酮剂量从10^-12到10^-6摩尔范围内诱导时,通过表达CAT酶做出反应,尽管强度和一致性各不相同。天然哺乳动物启动子在两种细胞系中在强度以及剂量依赖性表达谱方面表现出最一致的情况。我们的研究对在基于细胞的生物测定中使用病毒启动子来测量用于人类治疗的药物和激素的生物活性提出了质疑,并建议在将一种研究技术完全转化为用于药物筛选的基于细胞的生物测定时要谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d8/331422/e3f495a0d218/1479-5876-2-1-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验